Nomura America Finance, LLC has recently filed a pricing supplement for a new offering of leveraged buffered notes linked to the S&P 500 Futures Excess Return Index. This development is significant for the company as it seeks to enhance its product offerings and attract a broader range of investors.
Nomura America Finance operates under the SIC code 6211, which categorizes it as a firm in the Security Brokers, Dealers & Flotation Companies sector. The company is a subsidiary of Nomura Holdings, Inc., which is also involved in this offering as the guarantor. The filing was made on October 29, 2026, and is part of a series of recent filings that indicate a proactive approach to capitalizing on market opportunities.
The filing states, "Nomura America Finance, LLC is offering the leveraged buffered notes linked to the S&P 500 Futures Excess Return Index due May 9, 2030." These notes are unsecured securities, meaning that all payments on them are subject to the credit risk of both Nomura America Finance and its parent company, Nomura Holdings, Inc. The offering aims to provide investors with a unique exposure to the S&P 500 index while offering certain protections against market declines.
This new offering may affect a variety of stakeholders, including investors looking for innovative financial products, financial advisors seeking to diversify portfolios, and competitors in the securities market. By introducing these notes, Nomura America Finance positions itself to attract investors interested in leveraging their exposure to the S&P 500 index while managing potential risks.
Looking ahead, Nomura America Finance will continue to offer additional notes and may adjust pricing and terms based on market conditions. The filing does not specify what happens next, but the company is likely to monitor investor interest and market performance closely.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










